375 related articles for article (PubMed ID: 33593410)
21. Ovarian carcinoma metastatic to the breast.
Wadhwa J; Dawar R; Kumar L
Clin Oncol (R Coll Radiol); 1999; 11(6):419-21. PubMed ID: 10663336
[TBL] [Abstract][Full Text] [Related]
22. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
23. [A lump in the breast. A rare first symptom of ovarian cancer].
Hansen PB; Rasmussen JV; Bak M
Ugeskr Laeger; 1998 Apr; 160(16):2401-2. PubMed ID: 9571815
[TBL] [Abstract][Full Text] [Related]
24. Metastasis of breast carcinoma to a primary mucinous cystadenocarcinoma of the ovary.
Twaalfhoven FC; Fleuren GJ; Cornelisse CJ; Peters AA; Trimbos JB; Hogendoorn PC
Gynecol Oncol; 1994 Jan; 52(1):80-6. PubMed ID: 8307506
[TBL] [Abstract][Full Text] [Related]
25. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
26. [Non-primary solid malignancies of breast in needle core biopsy: a clinicopathological analysis of 23 cases].
Gu WQ; Wang L; Xu JC; Ping GQ; Han X; Wang C
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):331-336. PubMed ID: 38556815
[No Abstract] [Full Text] [Related]
27. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
28. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract][Full Text] [Related]
29. Solitary Gastric Metastasis from a Stage IA Serous Ovarian Carcinoma: A Case Report with Literature Review.
Mizuguchi K; Minato H; Yoshida I; Iwadare J; Kayahashi K; Mitani Y; Watanabe K
Intern Med; 2017; 56(8):915-919. PubMed ID: 28420839
[TBL] [Abstract][Full Text] [Related]
30. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Nonaka D; Chiriboga L; Soslow RA
Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
[TBL] [Abstract][Full Text] [Related]
31. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
[TBL] [Abstract][Full Text] [Related]
32. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
[TBL] [Abstract][Full Text] [Related]
33. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma.
Lotan TL; Ye H; Melamed J; Wu XR; Shih IeM; Epstein JI
Am J Surg Pathol; 2009 Jul; 33(7):1037-41. PubMed ID: 19238079
[TBL] [Abstract][Full Text] [Related]
35. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
36. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
[TBL] [Abstract][Full Text] [Related]
37. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases.
McCluggage WG; Hurrell DP; Kennedy K
Am J Surg Pathol; 2010 May; 34(5):735-41. PubMed ID: 20414103
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
40. Ovarian carcinoma metastasis to the breast case report and review of the literature.
Yamasaki H; Saw D; Zdanowitz J; Faltz LL
Am J Surg Pathol; 1993 Feb; 17(2):193-7. PubMed ID: 8422114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
